Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-27 @ 9:34 AM
Study NCT ID:
NCT00349934
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2006-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Sponsor:
Immutep S.A.S.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-07
First Submit QC Date:
None
Study First Post Date:
2006-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-01-06
Last Update Post Date:
2010-01-07
Last Update Post Date Type:
ESTIMATED